Association between hyperuricemia, prediabetes, and prehypertension in the Croatian adult population - a cross-sectional study

BMC Cardiovascular Disorders

Biserka Bergman Marković⁶  Ksenija Kranjčević²  Dragica Ivezić Lalić³  Davorka Vrdoljak¹  Ivan Bielen⁵  Milica Katić⁶  Jasna Vučak⁴ 

[1]Department of Family Medicine, School of Medicine University of Split, Split, Croatia

[2]Family Health Center, DZ Zapad, Zagreb, Croatia

[3]Family Health Center, Novska, Croatia

[4]Family Health Center, Ambulanta, Ulica XVIII Sukosan, Zadar, 23206, Croatia

[5]Department of neurology, Hospital “Sveti Duh”, Zagreb, Croatia

[6]Department of Family Medicine, School of Medicine University of Zagreb, Zagreb, Croatia

关键词: Prevalence;    Purine-rich food;    Prehypertension;    Prediabetes;    Hyperuricemia;   

Others  :  857952
DOI  :  10.1186/1471-2261-12-117

 received in 2012-09-12, accepted in 2012-11-29,  发布年份 2012

【 摘 要 】

Background

The association between hyperuricemia, hypertension, and diabetes has been proved to have strong association with the risk for cardiovascular diseases, but it is not clear whether hyperuricemia is related to the early stages of hypertension and diabetes. Therefore, in this study we investigated the association between hyperuricemia, prediabetes, and prehypertension in Croatian adults, as well as that between purine-rich diet and hyperuricemia, prediabetes, or prehypertension.

Methods

A stratified random representative sample of 64 general practitioners (GP) was selected. Each GP systematically chose participants aged ≥ 40 year (up to 55 subjects) . Recruitment occurred between May and September 2008. The medical history, anthropometric, and laboratory measures were obtained for each participant.

Results

59 physicians agreed to participate and recruited 2485 subjects (response rate 77%; average age (± standard deviation) 59.2 ±10.6; 61.9% women. In bivariate analysis we found a positive association between hyperuricemia and prediabetes (OR 1.66, 95% CI 1.09–2.53), but not for prehypertension (OR 1.68, 95% CI 0.76–3.72). After controlling for known confounders for cardiovascular disease (age, gender, body mass index, alcohol intake, diet, physical activity, waist to hip ratio, total cholesterol, low density lipoprotein, high density lipoprotein, and triglycerides), in multivariate analysis HU ceased to be an independent predictor(OR 1.33, CI 0.98–1.82, p = 0.069) for PreDM. An association between purine-rich food and hyperuricemia was found (p<0.001) and also for prediabetes (p=0.002), but not for prehypertension (p=0.41). The prevalence of hyperuricemia was 10.7% (15.4% male, 7.8% female), 32.5% for prediabetes (35.4% male, 30.8% female), and 26.6% for prehypertension (27.2% male, 26.2% female).

Conclusion

Hyperuricemia seems to be associated with prediabetes but not with prehypertension. Both, hyperuricemia and prediabetes were associated with purine-rich food and patients need to be advised on appropriate diet.

Trial registration

Current Controlled Trials ISRCTN31857696

【 授权许可】

   
2012 Vucak et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Feig DI, Kang D, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
• [2]Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB: Plasma uric acid and risk of type 2 diabetes in Chinese community. Clin Chem 2008, 54(2):310-316.
• [3]Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the apolipoprotein MOrtality RISk study (AMORIS). J Intern Med 2009, 266(6):558-570.
• [4]Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Bretler MMB: Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507.
• [5]Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver Dam. Diabetes Care 2002, 25:1790-1794.
• [6]Mazzali M, Hughes J, Kim YG, Jefferson A, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001, 38:1101-1106.
• [7]Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ: Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004, 66:281-287.
• [8]Dehghan A, van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31(2):361-362.
• [9]Kramer CK, von Muhlen D, Jassal SK, Barrett-Connor E: Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the rancho Bernardo study. Diabetes Care 2009, 32(7):1272-1273.
• [10]Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA 2000, 283(18):2404-2410.
• [11]Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk of cardiovascular disease and mortality: the Framingham heart study. Ann Intern Med 1999, 31:7-13.
• [12]Syamala S, Li J, Shankar A: Association between serum uric acid and prehypertension among US adults. J Hypertens 2007, 25(8):1583-1589.
• [13]Liang J, Xue Y, Zou C, Zhang T, Song H, Qi L: Serum uric acid and prehypertension among Chinese adults. J Hypertens 2009, 27:1761-1765.
• [14]Bhole V, Choi JWJ, Kim SW, de Vera M, Choi H: Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med 2010, 123(10):957-961.
• [15]Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007, 28:2375-2414.
• [16]Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Rocellla EJ, National High Blood Pressure Education Program Coordinating Committee: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003, 42(6):1206-1252.
• [17]Prediabetes FAQs: American diabetes association. 2012. http://www.diabetes.org/diabetes-basics/prevention/pre-diabetes/pre-diabetes-faqs.html webcite. Accessed Jan. 29.
• [18]Fam AG: Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002, 29:1350-1355.
• [19]Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, Yamakado M, Nagai R: Changes in waist circumference and body mass indeks in relation to changes in serum uric acid in Japanese individuals. J Rheumatol 2010, 37:410-416.
• [20]Loachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ: Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. Arthritis&Rheumatism 2008, 58(2):623-630.
• [21]Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications a new perspective on an old paradigm. Diabetes 1999, 48:1-9.
• [22]Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003, 42:474-480.
• [23]Kawamoto R, Tomita H, Oka Y, Ohtsuka N: Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med 2006, 45(9):605-614.
• [24]Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol 2006, 290:625-631.
• [25]Hayden MR, Tyagi SC: Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type1 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond) 2004, 19(1):10.
• [26]Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M: Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular factors in a developing country. BMC Publ Health 2004, 4-9.
• [27]Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J: The prevalence of hyperuricemia in a population of the coastal city of Qingdao. China. J Rheumatol 2006, 33:1346-1350.
• [28]Zhu Y, Pandya BJ, Choi HK: Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008. Arthritis & Rheumatism 2011, 63:3136-3141.
• [29]Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005, 45:28-33.
• [30]Butler R, Morris AD, Belch JJF, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35:746-751.